REVBREVELATION BIOSCIENCES, INC.

Nasdaq revbiosciences.com


$ 2.19 $ -0.14 (-6.36 %)    

Friday, 10-May-2024 10:09:14 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 2.06
$ 2.19
$ 0.00 x 0
$ 0.00 x 0
$ 2.19 - $ 2.19
$ 1.78 - $ 39.00
38,268
na
2.25M
$ 1.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-22-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-14-2022 03-31-2022 10-Q
10 04-15-2022 12-31-2021 10-K
11 10-29-2021 09-30-2021 10-Q
12 08-23-2021 06-30-2021 10-Q
13 06-22-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 revelation-biosciences-q1-eps-246-misses-177-estimate

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(2.46) per share which missed the analyst consensus estimate...

 revelation-biosciences-q4-eps-833-beats-1377-estimate

Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(8.33) per share which beat the analyst consensus estimate o...

 revelation-biosciences-presented-data-showing-pretreatment-with-gemini-improved-kidney-function-with-reduced-serum-blood-urea-nitrogen-and-creatinine-urine-c-reactive-protein-and-acute-kidney-injury-related-inflammation

Gemini is the company's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) for systemic administration....

 revelation-biosciences-commences-first-in-human-phase-1-clinical-study-of-gemini

 -Top-line data including safety, tolerability, and biomarker activity anticipated this summer--This Phase 1 clinical study dat...

 top-5-health-care-stocks-that-are-preparing-to-pump-in-february

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 why-skechers-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarte...

 why-meta-shares-are-trading-higher-by-over-16-here-are-20-stocks-moving-premarket

Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-...

 dow-jumps-250-points-honeywell-issues-weak-forecast

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow t...

 why-ch-robinson-shares-are-trading-lower-by-over-12-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-...

 crude-oil-gains-1-ism-manufacturing-pmi-tops-expectations

U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23...

 nasdaq-surges-100-points-us-jobless-claims-increase-to-224000

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the mark...

 why-nextracker-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket

Shares of Nextracker Inc. (NASDAQ: NXT) rose sharply during today’s pre-market trading after the company reported better-than-...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION